|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0300 - 0.0370|
|52 Week Range||0.0040 - 0.1000|
|Beta (3Y Monthly)||8.41|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BOCA RATON, Fla., Feb. 25, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (BPSR), today announced the appointment of George C. Shapiro, M.D. F.A.C.C. to its medical advisory board. In addition to serving on the Company's Advisory Board, Dr. Shapiro is assembling the medical advisory board for Organicell. Dr. Shapiro is a world-renowned cardiologist, a leading speaker on age-management medicine, the holder of two US patents, and had a fellowship in cardiovascular disease at Columbia Presbyterian Medical Center in New York.
BOCA RATON, Fla., Jan. 30, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (BPSR), today is providing its shareholders with an update on the Company's progress. As previously announced, on April 23, 2018, Management and Business Associates, LLC, a company controlled by Mr. Manuel Iglesias, acquired 51% of the Company and Mr. Iglesias became our Chief Executive Officer. Mr. Iglesias brings extensive industry experience and relationships to the Company.